Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update

The pathogenesis and treatment of inflammatory bowel disease (IBD) have been recently advanced, while it is still challenged with high morbidity and poor prognosis. Infliximab, a monoclonal antibody of tumor necrosis factor (TNF), has emerged as an efficient treatment with many clinical benefits suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yuan, Lu, Nonghua, Bai, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581271/
https://www.ncbi.nlm.nih.gov/pubmed/23484133
http://dx.doi.org/10.1155/2013/581631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581271/
https://www.ncbi.nlm.nih.gov/pubmed/23484133
http://dx.doi.org/10.1155/2013/581631

Ejemplares similares